Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 5.314.354.425.7610.63

What is the latest Working Capital/Sales ratio of INDOCO REMEDIES ?

The latest Working Capital/Sales ratio of INDOCO REMEDIES is 5.31 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20245.31
Mar20234.35
Mar20224.42
Mar20215.76
Mar202010.63

How is Working Capital/Sales of INDOCO REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2024 5.31
22.07
Mar2023 4.35
-1.58
Mar2022 4.42
-23.26
Mar2021 5.76
-45.81
Mar2020 10.63 -

Other Financial Ratios of INDOCO REMEDIES


Compare Working Capital/Sales ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹3,100.2 Cr 2.1% 4.3% -13.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,661.0 Cr -1.8% 2.7% 49.1% Stock Analytics
DIVIS LABORATORIES ₹160,496.0 Cr -0.2% -3.4% 57% Stock Analytics
CIPLA ₹121,970.0 Cr -0.7% 0.6% 22.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,877.0 Cr -1.8% 11.3% 18% Stock Analytics
ZYDUS LIFESCIENCES ₹98,163.2 Cr 1.9% 0.5% 41.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

2.1%

4.3%

-13.4%

SENSEX

0.7%

-2%

9.7%


You may also like the below Video Courses